209 related articles for article (PubMed ID: 16449100)
1. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.
LaRowe SD; Mardikian P; Malcolm R; Myrick H; Kalivas P; McFarland K; Saladin M; McRae A; Brady K
Am J Addict; 2006; 15(1):105-10. PubMed ID: 16449100
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
Mousavi SG; Sharbafchi MR; Salehi M; Peykanpour M; Karimian Sichani N; Maracy M
Arch Iran Med; 2015 Jan; 18(1):28-33. PubMed ID: 25556383
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
[TBL] [Abstract][Full Text] [Related]
4. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study.
Mardikian PN; LaRowe SD; Hedden S; Kalivas PW; Malcolm RJ
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):389-94. PubMed ID: 17113207
[TBL] [Abstract][Full Text] [Related]
5. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
[TBL] [Abstract][Full Text] [Related]
6. Is cocaine desire reduced by N-acetylcysteine?
LaRowe SD; Myrick H; Hedden S; Mardikian P; Saladin M; McRae A; Brady K; Kalivas PW; Malcolm R
Am J Psychiatry; 2007 Jul; 164(7):1115-7. PubMed ID: 17606664
[TBL] [Abstract][Full Text] [Related]
7. The effect of N-acetylcysteine and working memory training on cocaine use, craving and inhibition in regular cocaine users: correspondence of lab assessments and Ecological Momentary Assessment.
Schulte MHJ; Wiers RW; Boendermaker WJ; Goudriaan AE; van den Brink W; van Deursen DS; Friese M; Brede E; Waters AJ
Addict Behav; 2018 Apr; 79():24-31. PubMed ID: 29241082
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine reduces cocaine-seeking behavior and anterior cingulate glutamate/glutamine levels among cocaine-dependent individuals.
Woodcock EA; Lundahl LH; Khatib D; Stanley JA; Greenwald MK
Addict Biol; 2021 Mar; 26(2):e12900. PubMed ID: 32212237
[TBL] [Abstract][Full Text] [Related]
9. A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence.
LaRowe SD; Kalivas PW; Nicholas JS; Randall PK; Mardikian PN; Malcolm RJ
Am J Addict; 2013; 22(5):443-52. PubMed ID: 23952889
[TBL] [Abstract][Full Text] [Related]
10. The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report.
Gillin JC; Pulvirenti L; Withers N; Golshan S; Koob G
Biol Psychiatry; 1994 Jun; 35(11):843-9. PubMed ID: 8054406
[TBL] [Abstract][Full Text] [Related]
11. Amantadine may facilitate detoxification of cocaine addicts.
Alterman AI; Droba M; Antelo RE; Cornish JW; Sweeney KK; Parikh GA; O'Brien CP
Drug Alcohol Depend; 1992 Oct; 31(1):19-29. PubMed ID: 1330470
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity.
Kampman KM; Volpicelli JR; Mulvaney F; Alterman AI; Cornish J; Gariti P; Cnaan A; Poole S; Muller E; Acosta T; Luce D; O'Brien C
Drug Alcohol Depend; 2001 Jun; 63(1):69-78. PubMed ID: 11297832
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial.
Baldaçara L; Cogo-Moreira H; Parreira BL; Diniz TA; Milhomem JJ; Fernandes CC; Lacerda AL
J Clin Psychiatry; 2016 Mar; 77(3):398-406. PubMed ID: 27046312
[TBL] [Abstract][Full Text] [Related]
14. Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms.
Kampman KM; Volpicelli JR; Alterman AI; Cornish J; O'Brien CP
Am J Psychiatry; 2000 Dec; 157(12):2052-4. PubMed ID: 11097979
[TBL] [Abstract][Full Text] [Related]
15. Modulating effect of alcohol use on cocaine use.
Magura S; Rosenblum A
Addict Behav; 2000; 25(1):117-22. PubMed ID: 10708326
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.
Brodie JD; Case BG; Figueroa E; Dewey SL; Robinson JA; Wanderling JA; Laska EM
Am J Psychiatry; 2009 Nov; 166(11):1269-77. PubMed ID: 19651710
[TBL] [Abstract][Full Text] [Related]
17. Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence.
Tennant FS; Tarver AL
NIDA Res Monogr; 1984; 55():159-63. PubMed ID: 6443373
[TBL] [Abstract][Full Text] [Related]
18. Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial.
Nuijten M; Blanken P; van de Wetering B; Nuijen B; van den Brink W; Hendriks VM
Lancet; 2016 May; 387(10034):2226-34. PubMed ID: 27015909
[TBL] [Abstract][Full Text] [Related]
19. Effects of daily treatment with citicoline: a double-blind, placebo-controlled study in cocaine-dependent volunteers.
Licata SC; Penetar DM; Ravichandran C; Rodolico J; Palmer C; Berko J; Geaghan T; Looby A; Peters E; Ryan E; Renshaw PF; Lukas SE
J Addict Med; 2011 Mar; 5(1):57-64. PubMed ID: 21769048
[TBL] [Abstract][Full Text] [Related]
20. Cocaine withdrawal symptoms identify "Type B" cocaine-dependent patients.
Ahmadi J; Kampman K; Dackis C; Sparkman T; Pettinati H
Am J Addict; 2008; 17(1):60-4. PubMed ID: 18214724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
